Cisplatin and doxorubicin for invasive basal cell carcinoma of the eyelids.
作者信息
Neudorfer M, Merimsky O, Lazar M, Geyer O
机构信息
Department of Ophthalmology, Ichilov Hospital, Tel Aviv, Israel.
出版信息
Ann Ophthalmol. 1993 Jan;25(1):11-3.
PMID:8427483
Abstract
Cisplatin and doxorubicin were used in the treatment of recurrent invasive basal cell carcinoma (BCC) of the medial canthus and orbit. Complete remission was observed after treatment termination, and this was still evident five years later. Systemic chemotherapy offers an alternative mode of treatment for selected cases of advanced BCC.
摘要
Zotero 插件